Pharma

Your Article Summary

See Latest Articles

Medtronic to Seek Indication Expansion for Heart Failure Device Therapy
Medtronic, 05/13/09

Medtronic announced that it intends to seek U.S. Food and Drug Administration approval for the use of Cardiac Resynchronization Therapy in certain mildly symptomatic heart failure patients. CRT is a proven life-saving therapy for some patients with advanced stages of heart failure; however it is not currently approved for use in earlier stages, or mildly symptomatic patients.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/11/09

Recombinant Human Erythropoietin, Epogin Injection Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09

Synthon announces European approvals for Raloxifene
Synthon, 12/08/09

 See all of Drug/Product Approvals